clarithromycin

Ukraine

Drugs containing this active substance

  • AZIKLAR 250

    The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, odontogenic infections (related to teeth), as well as for the eradication of H. pylori in cases of duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: Flamingo Pharmaceuticals Ltd.

  • The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, as well as odontogenic infections (related to teeth). It is also used for the eradication of H. pylori in duodenal ulcers and for the treatment of mycobacterial infections.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: Flamingo Pharmaceuticals Ltd.

  • The drug is used to treat infections caused by microorganisms sensitive to it. Specifically, it is prescribed for lower respiratory tract infections (bronchitis, pneumonia), upper respiratory tract infections (sinusitis, pharyngitis), as well as skin and soft tissue infections.

    Form: tablets, prolonged-release, coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: San Pharmaceutical Industries Limited

  • The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, acute and chronic odontogenic infections, as well as for the eradication of H. pylori in duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

  • The drug is used to treat infections of the upper and lower respiratory tract (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, as well as acute and chronic dental infections. It is also used for the eradication of H. pylori in duodenal ulcers and for the treatment of certain mycobacterial infections.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: AbbVie S.r.l.

  • The drug is used to treat lower respiratory tract infections (bronchitis, pneumonia), upper respiratory tract infections (tonsillitis, pharyngitis, sinus infections), otitis media, as well as skin and soft tissue infections and certain mycobacterial infections.

    Form: granules for oral suspension

    Active substance Dosage
    clarithromycin 125 mg/5 ml

    ATC: J01FA09

    Manufacturer: AbbVie S.r.l.

  • The drug is used to treat lower and upper respiratory tract infections (e.g., bronchitis, pharyngitis, sinusitis, otitis), skin and soft tissue infections, as well as mycobacterial infections.

    Form: granules for oral suspension

    Active substance Dosage
    clarithromycin 250 mg/5 ml

    ATC: J01FA09

    Manufacturer: AbbVie S.r.l.

  • The drug is prescribed for the treatment of infections caused by microorganisms sensitive to it. Specifically, these include upper and lower respiratory tract infections, skin and soft tissue infections, as well as mycobacterial infections (e.g., in patients with HIV).

    Form: powder, lyophilized for infusion solution

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: Delpharm Saint-Rémy

  • The drug is prescribed for adults and children aged 12 years and older for the treatment of lower respiratory tract infections (bronchitis, pneumonia), upper respiratory tract infections (sinusitis, pharyngitis), as well as skin and soft tissue infections.

    Form: tablets, film-coated, prolonged release

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: AbbVie S.r.l.

  • The drug is used to treat bacterial infections such as pharyngitis, pneumonia (mild and moderate), sinusitis, exacerbation of chronic bronchitis, and skin and soft tissue infections. It is also used for the eradication of Helicobacter pylori in peptic ulcer disease (as part of combination therapy).

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: Aurobindo Pharma Limited - Unit III

  • The drug is used to treat bacterial infections such as pharyngitis, pneumonia, sinusitis, exacerbation of chronic bronchitis, and skin and soft tissue infections. It is also used in combination therapy to eradicate Helicobacter pylori in peptic ulcer disease.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: Aurobindo Pharma Limited - Unit III

  • The drug is used to treat upper and lower respiratory tract infections (e.g., bronchitis, pneumonia, tonsillitis, pharyngitis), skin and soft tissue infections, odontogenic infections (related to teeth), as well as for the eradication of H. pylori in duodenal ulcers and the treatment of mycobacterial infections.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: PJSC "Kyivmedpreparat"

  • The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, odontogenic (tooth) infections, as well as for the eradication of H. pylori in duodenal ulcers and certain mycobacterial infections.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: PJSC "Kyivmedpreparat"

  • The drug is used to treat upper and lower respiratory tract infections (e.g., tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, as well as acute and chronic dental infections. It is also used to treat mycobacterial infections and to eradicate Helicobacter pylori in patients with duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: Artura Pharmaceuticals Pvt. Ltd.

  • The drug is used to treat upper and lower respiratory tract infections (e.g., tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, as well as odontogenic infections (related to teeth). It is also used for the eradication of H. pylori in duodenal ulcers and for the treatment of certain mycobacterial infections.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: Artura Pharmaceuticals Pvt. Ltd.

  • The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, odontogenic (tooth) infections, as well as for the eradication of H. pylori in patients with duodenal ulcers and for the treatment of mycobacterial infections.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: ASTRAFARM LLC

  • The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, odontogenic infections (related to teeth), as well as for the eradication of H. pylori bacteria in duodenal ulcers and the treatment of mycobacterial infections.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: ASTRAFARM LLC

  • The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, odontogenic infections (related to teeth), as well as for the eradication of H. pylori bacteria in duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

  • The drug is used to treat infections caused by microorganisms sensitive to it. Specifically, it is used for upper respiratory tract infections (tonsillitis, pharyngitis) and lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections, odontogenic infections, as well as for the eradication of H. pylori in duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

  • The drug is used to treat infections caused by microorganisms sensitive to it, including upper and lower respiratory tract infections, skin and soft tissue infections, as well as mycobacterial infections (e.g., in HIV patients).

    Form: powder, lyophilized for infusion solution

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: Immacul Lifesciences Private Limited

  • The drug is used to treat upper and lower respiratory tract infections (e.g., bronchitis, pneumonia, pharyngitis), skin infections, odontogenic (dental) infections, as well as for the eradication of H. pylori in duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)

  • The drug is used to treat upper and lower respiratory tract infections (e.g., bronchitis, pneumonia, pharyngitis), skin infections, odontogenic infections (related to teeth), as well as for the eradication of H. pylori in duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)

  • The drug is used to treat gastric and duodenal ulcers, as well as chronic gastritis caused by H. pylori bacteria.

    Form: tablets, coated, capsules

    Active substance Dosage
    clarithromycin 250 mg
    tinidazole 500 mg
    lansoprazole 30 mg

    ATC: A02BD09

    Manufacturer: Evertoxgen Life Sciences Limited

  • The drug is prescribed for the treatment of upper respiratory tract infections (tonsillitis, pharyngitis), paranasal sinus infections, lower respiratory tract infections (bronchitis, pneumonia), acute otitis media, as well as skin infections, soft tissue infections, and mycobacterial infections.

    Form: granules for oral suspension

    Active substance Dosage
    clarithromycin 125 mg/5 ml

    ATC: J01FA09

    Manufacturer: KRKA, d.d., Novo mesto (secondary packaging, batch control and batch release) / KRKA, d.d., Novo mesto (manufacturing 'in bulk', primary and secondary packaging)

  • The drug is used to treat infections caused by susceptible bacteria, specifically lower and upper respiratory tract infections (bronchitis, pneumonia, tonsillitis, pharyngitis), otitis, skin infections, as well as mycobacterial infections.

    Form: suspension, oral, powder for oral suspension

    Active substance Dosage
    clarithromycin 250 mg/5 ml

    ATC: J01FA09

    Manufacturer: KRKA, d.d., Novo Mesto (secondary packaging, batch control and batch release) / KRKA, d.d., Novo Mesto (manufacturing 'in bulk', primary and secondary packaging) / KRKA, d.d., Novo Mesto (batch control (physical and chemical control methods))

  • The drug is used to treat lower and upper respiratory tract infections (bronchitis, pneumonia, tonsillitis, pharyngitis), skin and soft tissue infections, odontogenic infections (related to teeth), as well as for the eradication of Helicobacter pylori in cases of duodenal ulcer.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: KRKA, d.d., Novo mesto (manufacturing "in bulk", primary and secondary packaging, batch control and batch release) / KRKA, d.d., Novo mesto (batch control)

  • The drug is used to treat lower and upper respiratory tract infections (bronchitis, pneumonia, tonsillitis, pharyngitis, sinus infections), skin and soft tissue infections, acute and chronic dental infections, as well as for the eradication of Helicobacter pylori in cases of duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: KRKA, d.d., Novo mesto (manufacturing "in bulk", primary and secondary packaging, batch control and batch release) / KRKA, d.d., Novo mesto (batch control)

  • The drug is used to treat infections caused by susceptible bacteria. Specifically, it is indicated for lower respiratory tract infections (bronchitis, pneumonia), upper respiratory tract infections (sinusitis, pharyngitis), as well as skin and soft tissue infections.

    Form: tablets, modified release

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: KRKA, d.d., Novo mesto

  • The drug is used to treat infections of the upper and lower respiratory tract (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, odontogenic (tooth) infections, as well as for the eradication of H. pylori bacteria in duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: Sanovel Ilac Sanai ve Ticaret A.S.

  • The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, odontogenic (dental) infections, as well as for the eradication of H. pylori bacteria in duodenal ulcers. It is also used for mycobacterial infections.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: Sanovel Ilac Sanai ve Ticaret A.S.

  • The drug is prescribed to adults and children aged 12 and older for the treatment of lower respiratory tract infections (bronchitis, pneumonia), upper respiratory tract infections (sinusitis, pharyngitis), as well as infectious diseases of the skin and soft tissues (folliculitis, erysipelas).

    Form: tablets, modified release

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: Sanovel Ilac Sanai ve Ticaret A.S.

  • The drug is used to treat upper and lower respiratory tract infections (tonsillitis, pharyngitis, bronchitis, pneumonia), skin and soft tissue infections, odontogenic infections (related to teeth), as well as for the eradication of H. pylori bacteria in duodenal ulcers.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 250 mg

    ATC: J01FA09

    Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.

  • The drug is used to treat infections of the upper and lower respiratory tract (e.g., bronchitis, pneumonia, pharyngitis, tonsillitis), skin and soft tissue infections, odontogenic infections (related to teeth), as well as for the eradication of Helicobacter pylori in cases of duodenal ulcer.

    Form: tablets, film-coated

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.

  • The drug is used to treat infections caused by microorganisms sensitive to it. Specifically, it is prescribed for upper and lower respiratory tract infections, skin and soft tissue infections, as well as mycobacterial infections.

    Form: powder for solution for infusion

    Active substance Dosage
    clarithromycin 500 mg

    ATC: J01FA09

    Manufacturer: Mefar Ilac San. A.S.

  • The drug is intended for the eradication (removal) of Helicobacter pylori bacteria in patients with gastric and duodenal ulcers.

    Form: tablets, coated and capsules

    Active substance Dosage
    amoxicillin 1000 mg
    clarithromycin 500 mg
    omeprazole 20 mg

    ATC: A02BD05

    Manufacturer: San Pharmaceutical Industries Limited